Ralph S. Mazenko

678 total citations
16 papers, 545 citations indexed

About

Ralph S. Mazenko is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Ralph S. Mazenko has authored 16 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 5 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Ralph S. Mazenko's work include Inflammatory mediators and NSAID effects (8 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Ralph S. Mazenko is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Ralph S. Mazenko collaborates with scholars based in United States, Germany and Canada. Ralph S. Mazenko's co-authors include Jeffrey D. Brewster, Andrew Gehring, C. Gerald Crawford, Eric Woolf, Nancy Agrawal, C. Crawford, B.K. Matuszewski, Kerstin Malmström, Aditi Sapre and James R. Fricke and has published in prestigious journals such as Analytical Chemistry, Journal of Pharmaceutical Sciences and Journal of Immunological Methods.

In The Last Decade

Ralph S. Mazenko

16 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph S. Mazenko United States 13 204 185 165 74 73 16 545
Carolina Colliva Italy 12 109 0.5× 205 1.1× 131 0.8× 36 0.5× 86 1.2× 14 571
H. Yoshida Japan 14 70 0.3× 214 1.2× 61 0.4× 50 0.7× 19 0.3× 36 653
Thomas Mercier Switzerland 17 39 0.2× 136 0.7× 184 1.1× 130 1.8× 90 1.2× 33 685
Haonan Wang China 16 45 0.2× 334 1.8× 63 0.4× 41 0.6× 43 0.6× 32 699
M. Kunst Netherlands 14 46 0.2× 103 0.6× 78 0.5× 40 0.5× 15 0.2× 26 433
Susan Fowles United Kingdom 11 65 0.3× 136 0.7× 152 0.9× 36 0.5× 37 0.5× 15 587
Tuba Reçber Türkiye 10 69 0.3× 254 1.4× 78 0.5× 26 0.4× 31 0.4× 46 552
Sunyoung Ahn South Korea 12 36 0.2× 105 0.6× 38 0.2× 81 1.1× 26 0.4× 35 494
Y Kawakami Japan 13 58 0.3× 238 1.3× 225 1.4× 110 1.5× 5 0.1× 61 957
Te‐Yu Hung Taiwan 15 25 0.1× 158 0.9× 58 0.4× 73 1.0× 119 1.6× 33 804

Countries citing papers authored by Ralph S. Mazenko

Since Specialization
Citations

This map shows the geographic impact of Ralph S. Mazenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph S. Mazenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph S. Mazenko more than expected).

Fields of papers citing papers by Ralph S. Mazenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph S. Mazenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph S. Mazenko. The network helps show where Ralph S. Mazenko may publish in the future.

Co-authorship network of co-authors of Ralph S. Mazenko

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph S. Mazenko. A scholar is included among the top collaborators of Ralph S. Mazenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph S. Mazenko. Ralph S. Mazenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Wang, Haiping, K.M. Anderson, Paul Harradine, et al.. (2014). Understanding and Reducing the Experimental Variability of In Vitro Plasma Protein Binding Measurements. Journal of Pharmaceutical Sciences. 103(10). 3302–3309. 16 indexed citations
3.
Malmström, Kerstin, et al.. (2004). Etoricoxib in acute pain associated with dental surgery: A randomized, double-blind, placebo- and active comparator-controlled dose-ranging study. Clinical Therapeutics. 26(5). 667–679. 69 indexed citations
4.
Agrawal, Nancy, Catherine Z. Matthews, Ralph S. Mazenko, et al.. (2004). The Effects of Modifying In Vivo Cytochrome P450 3A (CYP3A) Activity on Etoricoxib Pharmacokinetics and of Etoricoxib Administration on CYP3A Activity. The Journal of Clinical Pharmacology. 44(10). 1125–1131. 19 indexed citations
5.
Agrawal, Nancy, Catherine Z. Matthews, Ralph S. Mazenko, et al.. (2003). Pharmacokinetics of Etoricoxib in Patients with Renal Impairment. The Journal of Clinical Pharmacology. 44(1). 48–58. 32 indexed citations
6.
Schwartz, Jules I., Patrick Larson, Arturo G. Porras, et al.. (2003). Pharmacokinetic Evaluation of Rofecoxib. Clinical Drug Investigation. 23(8). 503–509. 2 indexed citations
7.
Bachmann, Kenneth, Donald B. White, Luis Jáuregui, et al.. (2003). An Evaluation of the Dose‐Dependent Inhibition of CYP1A2 by Rofecoxib Using Theophylline as a CYP1A2 Probe. The Journal of Clinical Pharmacology. 43(10). 1082–1090. 21 indexed citations
8.
Matthews, Catherine Z., Eric Woolf, Ralph S. Mazenko, et al.. (2002). Determination of efavirenz, a selective non-nucleoside reverse transcriptase inhibitor, in human plasma using HPLC with post-column photochemical derivatization and fluorescence detection. Journal of Pharmaceutical and Biomedical Analysis. 28(5). 925–934. 38 indexed citations
9.
Halpin, Rita A., Arturo G. Porras, Leslie A. Geer, et al.. (2002). The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects. Drug Metabolism and Disposition. 30(6). 684–693. 38 indexed citations
10.
Vallano, Patrick T., Ralph S. Mazenko, Eric Woolf, & B.K. Matuszewski. (2002). Monolithic silica liquid chromatography columns for the determination of cyclooxygenase II inhibitors in human plasma. Journal of Chromatography B. 779(2). 249–257. 31 indexed citations
11.
12.
Mazenko, Ralph S., Fredric Rieders, & Jeffrey D. Brewster. (1999). Filtration capture immunoassay for bacteria: optimization and potential for urinalysis. Journal of Microbiological Methods. 36(3). 157–165. 25 indexed citations
13.
Brewster, Jeffrey D. & Ralph S. Mazenko. (1998). Filtration capture and immunoelectrochemical detection for rapid assay of Escherichia coli O157:H7. Journal of Immunological Methods. 211(1-2). 1–8. 54 indexed citations
14.
Campbell, Naomi F., et al.. (1997). Development of a chromatographic method for the isolation and detection of hygromycin B in biological fluids. Journal of Chromatography B Biomedical Sciences and Applications. 692(2). 367–374. 3 indexed citations
15.
Gehring, Andrew, et al.. (1996). Enzyme-linked immunomagnetic electrochemical detection of Salmonella typhimurium. Journal of Immunological Methods. 195(1-2). 15–25. 102 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carolina Colliva Breakdown of academic impact, for papers by H. Yoshida Breakdown of academic impact, for papers by Thomas Mercier Breakdown of academic impact, for papers by Haonan Wang Breakdown of academic impact, for papers by M. Kunst Breakdown of academic impact, for papers by Susan Fowles Breakdown of academic impact, for papers by Tuba Reçber Breakdown of academic impact, for papers by Sunyoung Ahn Breakdown of academic impact, for papers by Y Kawakami Breakdown of academic impact, for papers by Te‐Yu Hung
Rankless by CCL
2026